Literature DB >> 18042093

Clinical manifestations of cutaneous lupus erythematosus.

Annegret Kuhn1, Michael Sticherling, Gisela Bonsmann.   

Abstract

Cutaneous lupus erythematosus (CLE) is a chronic inflammatory autoimmune disease with a broad spectrum of clinical manifestations and a variable course. In numerous investigations, it has been shown that exogenous factors, such as UV-light and drugs, can induce this disease. However, not all clinical aspects can be explained and therefore, the pathogenesis of CLE is currently under extensive research. The various cutaneous manifestations of LE are divided into LE-nonspecific and LE-specific skin disease based on histologic criteria. LE-nonspecific manifestations are mostly associated with systemic LE but can also occur in other diseases and include particularly vascular skin lesions such as pe-riungual telangiectases. LE-specific skin disease includes the subtypes of CLE such as acute cutaneous LE (ACLE), subacute cutaneous LE (SCLE), chronic cutaneous LE (CCLE), and intermittent CLE (ICLE). The subdivision of these subtypes with different prognosis and course is supported by genetic, clinical, histologic, and immunoserologic findings. The subtypes of CLE require a specific morphological and clinical analysis, which is described in the first part of this review. In the second part of this review, further diagnostic procedures and therapeutic strategies in patients with CLE are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042093     DOI: 10.1111/j.1610-0387.2007.06554.x

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  16 in total

Review 1.  [Skin signs of systemic diseases].

Authors:  St Lautenschlager
Journal:  Internist (Berl)       Date:  2009-02       Impact factor: 0.743

2.  Chilblain lupus erythematosus.

Authors:  Sapna Patel; Faddy Hardo
Journal:  BMJ Case Rep       Date:  2013-11-27

3.  [Involvement of mucous membranes in papulosquamous diseases].

Authors:  M Sticherling
Journal:  Hautarzt       Date:  2009-11       Impact factor: 0.751

Review 4.  Intravenous immunoglobulins for treatment of connective tissue diseases in dermatology.

Authors:  Lyubomir A Dourmishev; Dimitrina V Guleva; Ljubka G Miteva
Journal:  Wien Med Wochenschr       Date:  2017-09-01

5.  Identification and molecular analysis of glycosaminoglycans in cutaneous lupus erythematosus and dermatomyositis.

Authors:  Laura M Chang; Prateesh Maheshwari; Sheila Werth; Lana Schaffer; Steven R Head; Carrie Kovarik; Victoria P Werth
Journal:  J Histochem Cytochem       Date:  2011-01-12       Impact factor: 2.479

6.  Familial cutaneous lupus erythematosus (CLE) in the German shorthaired pointer maps to CFA18, a canine orthologue to human CLE.

Authors:  Ping Wang; Barbara Zangerl; Petra Werner; Elizabeth A Mauldin; Margret L Casal
Journal:  Immunogenetics       Date:  2010-12-04       Impact factor: 2.846

Review 7.  [Lupus erythematosus].

Authors:  C Günther; S Beissert
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

8.  [Genetics of lupus erythematosus].

Authors:  Claudia Günther
Journal:  Hautarzt       Date:  2015-02       Impact factor: 0.751

Review 9.  Cutaneous lupus erythematosus: diagnosis and treatment.

Authors:  L G Okon; V P Werth
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-06       Impact factor: 4.098

10.  Cutaneous manifestations of systemic lupus erythematosus.

Authors:  Luís Uva; Diana Miguel; Catarina Pinheiro; João Pedro Freitas; Manuel Marques Gomes; Paulo Filipe
Journal:  Autoimmune Dis       Date:  2012-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.